BAVA Bavarian Nordic A/S

Resolutions of the Annual General Meeting 2024 of Bavarian Nordic A/S

Resolutions of the Annual General Meeting 2024 of Bavarian Nordic A/S

COPENHAGEN, Denmark, April 16, 2024 – Bavarian Nordic A/S (OMX: BAVA) today held the Annual General Meeting with the following results:

  • The Annual Report for 2023 was adopted. The Board of Directors’ proposal to transfer the Company’s result to 2024 was also adopted.
  • The Remuneration Report for 2023 was approved.
  • The Board of Directors and the Board of Management were discharged from liability.
  • Luc Debryune, Anders Gersel Pedersen, Frank Verwiel, Anne Louise Eberhard, Heidi Hunter and Johan van Hoof were re-elected, and Montse Montaner was elected to the Board of Directors. The Board of Directors constituted itself with Luc Debruyne as Chairman and Anders Gersel Pedersen as Deputy Chairman.
  • KPMG was elected as the Company’s new auditor.
  • The proposal to authorize the Board of Directors to increase the share capital of the Company was adopted.
  • The proposal to authorize the Board of Directors to issue convertible notes which give the right to subscribe for new shares in the Company was adopted.
  • The proposal to authorize the Board of Directors to issue warrants was adopted.
  • The Remuneration Policy was approved.
  • The proposed remuneration of the Board of Directors and the Board Committees for the current financial year was approved.
  • The proposal to authorize the Board of Directors on behalf of the Company to purchase own shares in the Company was adopted.

Minutes and voting results from the Annual General Meeting will be published on the Company’s website within two weeks.

About Bavarian Nordic

Bavarian Nordic is a fully integrated vaccine company with a mission to protect and save lives through innovative vaccines. We are a global leader in smallpox and mpox vaccines, supplied to governments to enhance public health preparedness and have a strong portfolio of vaccines for travelers and endemic diseases. For more information visit .

Contacts

Europe: Rolf Sass Sørensen, Vice President Investor Relations, Tel:

US: Graham Morrell, Paddock Circle Advisors, , Tel:

Company Announcement no. 07 / 2024

Attachment



EN
16/04/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Bavarian Nordic A/S

 PRESS RELEASE

Indberetning af ledende medarbejdere og disses nærtståendes transaktio...

Indberetning af ledende medarbejdere og disses nærtståendes transaktioner med Bavarian Nordic aktier og tilknyttede værdipapirer KØBENHAVN, Danmark, 12. marts 2026 – Bavarian Nordic A/S (OMX: BAVA) har dags dato modtaget oplysninger om følgende transaktioner med selskabets aktie/tilknyttede værdipapirer, foretaget af ledende medarbejdere og/eller personer/firmaer der er nærtstående til disse, hvilke hermed offentliggøres i overensstemmelse med §19 i Europa Parlamentets og Rådets forordning (EU) nr. 596/2014 samt Kommissionens Gennemførelsesforordning (EU) nr. 2016/523. Transaktionerne ved...

 PRESS RELEASE

Report of transactions of shares and related securities of Bavarian No...

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such COPENHAGEN, Denmark, March 12, 2026 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the Company’s shares/related securities by persons holding managerial responsibilities and/or persons/companies closely associated with such, which are hereby reported in accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523. The ...

 PRESS RELEASE

Bavarian Nordic lancerer næste del af aktietilbagekøbsprogram

Bavarian Nordic lancerer næste del af aktietilbagekøbsprogram KØBENHAVN, Danmark, 12. marts 2026 – Bavarian Nordic A/S (OMX: BAVA) iværksætter nu den anden del af det planlagte aktietilbagekøbsprogram, hvorunder selskabet vil tilbagekøbe egne aktier for op til DKK 500 mio. i løbet af 2026. Den første del, som blev afsluttet tidligt i februar 2026, omfattede tilbagekøb af aktier for DKK 150 mio. Den anden del vil omfatte tilbagekøb af aktier for op til DKK 200 mio., som selskabet også vil beholde som egne aktier med det formål at tilpasse kapitalstrukturen. Aktietilbagekøbsprogrammet iværk...

 PRESS RELEASE

Bavarian Nordic Launches Next Tranche of Share Buy-Back Program

Bavarian Nordic Launches Next Tranche of Share Buy-Back Program COPENHAGEN, Denmark, March 12, 2026 – Bavarian Nordic A/S (OMX: BAVA) today launches the second tranche of the planned buy-back program, under which the Company intends to repurchase own shares for up to DKK 500 million during 2026. The first tranche, completed in early February 2026, comprised buy-back of shares for DKK 150 million. The second tranche will comprise buy-back of shares for DKK 200 million, also to be held as treasury stock for the purpose of adjusting the capital structure. The share buy-back program is initia...

 PRESS RELEASE

Bavarian Nordic offentliggør årsrapport for 2025

Bavarian Nordic offentliggør årsrapport for 2025 KØBENHAVN, Danmark, 12. marts 2026 – Bavarian Nordic A/S (OMX: BAVA) offentliggjorde i dag årsrapporten for 2025. De konsoliderede og reviderede finansielle resultater var i overensstemmelse med de foreløbige resultater, der blev offentliggjort den 12. februar 2026. Årsrapporten er vedhæftet og er desuden tilgængelig via . “Vores årsrapport for 2025 bekræfter de stærke foreløbige resultater, vi rapporterede i sidste måned, og vi er godt i gang med at gennemføre vores planer for 2026 med henblik på at levere fortsat vækst i vores Travel Healt...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch